Literature DB >> 17106932

Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats.

Maria-Angeles Aller1, Elena Vara, Cruz García, Maria-Paz Nava, Alejandra Angulo, Fernando Sánchez-Patán, Ana Calderón, Patri Vergara, Jaime Arias.   

Abstract

AIM: To verify the impairment of the hepatic lipid metabolism in prehepatic portal hypertension.
METHODS: The concentrations of free fatty acids, diacylglycerol, triglycerides, and phospholipids were assayed by using D-[U-14C] glucose incorporation in the different lipid fractions and thin-layer chromatography and cholesterol was measured by spectrophotometry, in liver samples of Wistar rats with partial portal vein ligation at short- (1 mo) and long-term (1 year) (i.e. portal hypertensive rats) and the control rats.
RESULTS: In the portal hypertensive rats, liver phospholipid synthesis significantly decreased (7.42 +/- 0.50 vs 4.70 +/- 0.44 nCi/g protein; P < 0.01) and was associated with an increased synthesis of free fatty acids (2.08 +/- 0.14 vs 3.36 +/- 0.33 nCi/g protein; P < 0.05), diacylglycerol (1.93 +/- 0.2 vs 2.26 +/- 0.28 nCi/g protein), triglycerides (2.40 +/- 0.30 vs 4.49 +/- 0.15 nCi/g protein) and cholesterol (24.28 +/- 2.12 vs 57.66 +/- 3.26 mg/g protein; P < 0.01).
CONCLUSION: Prehepatic portal hypertension in rats impairs the liver lipid metabolism. This impairment consists in an increase in lipid deposits (triglycerides, diacylglycerol and cholesterol) in the liver, accompanied by a decrease in phospholipid synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106932      PMCID: PMC4087438          DOI: 10.3748/wjg.v12.i42.6828

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

Review 1.  Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.

Authors:  Steven F Solga; A M Diehl
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

Review 2.  Cytokine regulation of liver injury and repair.

Authors:  A M Diehl
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

3.  Vascular reactivity in experimental portal hypertension.

Authors:  A Bomzon; L M Blendis
Journal:  Am J Physiol       Date:  1987-02

4.  Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat.

Authors:  Isabel Prieto; María-Angeles Aller; Luis Santamaría; María-Paz Nava; Rosario Madero; Juan-Pedro Pérez-Robledo; Jaime Arias
Journal:  J Gastroenterol Hepatol       Date:  2005-07       Impact factor: 4.029

5.  Insulin resistance in NASH.

Authors:  J Choudhury; A J Sanyal
Journal:  Front Biosci       Date:  2005-05-01

6.  Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.

Authors:  Shinji Tamura; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 7.  Peroxynitrite-mediated mitochondrial dysfunction.

Authors:  J Boczkowski; C L Lisdero; S Lanone; M C Carreras; M Aubier; J J Poderoso
Journal:  Biol Signals Recept       Date:  2001 Jan-Apr

Review 8.  Mitochondrial injury in steatohepatitis.

Authors:  Dominique Pessayre; Bernard Fromenty; Abdellah Mansouri
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

Review 9.  The ins and outs of mitochondrial dysfunction in NASH.

Authors:  B Fromenty; M A Robin; A Igoudjil; A Mansouri; D Pessayre
Journal:  Diabetes Metab       Date:  2004-04       Impact factor: 6.041

10.  Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats.

Authors:  Maria Angeles Aller; Elena Vara; Cruz Garcia; Maria Dolores Palma; Jorge L Arias; Maria Paz Nava; Jaime Arias
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

View more
  9 in total

1.  Brain metabolism and spatial memory are affected by portal hypertension.

Authors:  Natalia Arias; Marta Méndez; Jaime Arias; Jorge L Arias
Journal:  Metab Brain Dis       Date:  2012-06       Impact factor: 3.584

2.  Low-light-level therapy as a treatment for minimal hepatic encephalopathy: behavioural and brain assessment.

Authors:  Natalia Arias; Marta Méndez; Jorge L Arias
Journal:  Lasers Med Sci       Date:  2016-08-03       Impact factor: 3.161

3.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

Review 4.  Splanchnic-aortic inflammatory axis in experimental portal hypertension.

Authors:  Maria-Angeles Aller; Natalia de las Heras; Maria-Paz Nava; Javier Regadera; Jaime Arias; Vicente Lahera
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  A half century (1961-2011) of applying microsurgery to experimental liver research.

Authors:  Maria-Angeles Aller; Natalia Arias; Isabel Prieto; Salvador Agudo; Carlos Gilsanz; Laureano Lorente; Jorge-Luis Arias; Jaime Arias
Journal:  World J Hepatol       Date:  2012-07-27

Review 6.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

Review 7.  Embrionary way to create a fatty liver in portal hypertension.

Authors:  Maria-Angeles Aller; Natalia Arias; Isabel Peral; Sara García-Higarza; Jorge-Luis Arias; Jaime Arias
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

8.  Chronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome?

Authors:  Fernando Sánchez-Patán; Raquel Anchuelo; Maria-Angeles Aller; Elena Vara; Cruz García; Maria-Paz Nava; Jaime Arias
Journal:  Lipids Health Dis       Date:  2008-02-13       Impact factor: 3.876

Review 9.  The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jaime Arias
Journal:  J Transl Med       Date:  2007-09-24       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.